Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Illumina Inc (ILMN)  
$123.05 1.68 (1.35%) as of 4:30 Tue 4/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 146,000,000
Market Cap: 17.97(B)
Last Volume: 1,136,933 Avg Vol: 1,328,632
52 Week Range: $92.79 - $212.65
Level I Sector: Information Technology
Level II Sector: Electronics
Level III Sector: Scientific & Technical Instruments

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    : 11.4
Insider 6 Months    : 11.4
Insider 3/6 Months : 23.2
Guru Rank Number :  691
Guru Rank Value     : 2.3
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 7,330 7,330 7,330 7,330
Total Buy Value $991,672 $991,672 $991,672 $991,672
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 0 315 6,815 22,740
Total Sell Value $0 $35,545 $1,357,080 $4,648,975
Total People Sold 0 1 2 3
Total Sell Transactions 0 1 5 17
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 3453
  Page 8 of 139  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Reeves Kathryne Gambrell SVP, Chief Marketing Officer   •       •      –    2021-10-05 4 D $387.98 $32,202 D/D (83) 2,484     -
   Goswami Joydeep SVP Corp Business Development   •       •      –    2021-10-05 4 D $387.98 $44,618 D/D (115) 4,053     -
   Tousi Susan H SVP, Chief Commercial Officer   •       •      –    2021-09-28 4 AS $418.04 $41,804 D/D (100) 41,356 -14%     
   Dadswell Charles SVP & General Counsel   •       •      –    2021-09-22 4 AS $436.69 $137,121 I/I (314) 4,972 -18%     
   Tousi Susan H SVP, Chief Commercial Officer   •       •      –    2021-08-30 4 AS $463.50 $139,050 D/D (300) 41,456 -21%     
   Dadswell Charles SVP & General Counsel   •       •      –    2021-08-23 4 AS $489.10 $153,577 I/I (314) 5,286 -20%     
   Aravanis Alexander SVP, Chief Technology Officer   •       •      –    2021-08-18 4 D $510.61 $5,080,059 D/D (9,949) 16,383     -
   Aravanis Alexander SVP, Chief Technology Officer   •       •      –    2021-08-18 4 A $510.61 $11,056,238 D/D 21,653 26,332     -
   Hoyt Aimee L SVP, Chief People Officer   •       •      –    2021-08-04 4 AS $500.00 $186,000 D/D (372) 3,757 -25%     
   Tousi Susan H SVP, Chief Commercial Officer   •       •      –    2021-08-04 4 AS $500.00 $500,000 D/D (1,000) 41,756 -25%     
   Tousi Susan H SVP, Chief Commercial Officer   •       •      –    2021-07-28 4 AS $486.41 $145,923 D/D (300) 42,743 -29%     
   Dadswell Charles SVP & General Counsel   •       •      –    2021-07-22 4 AS $482.23 $151,420 I/I (314) 5,576 -24%     
   Aravanis Alexander SVP, Chief Technology Officer   •       •      –    2021-07-07 4 AS $477.59 $257,421 D/D (539) 4,679 -19%     
   Aravanis Alexander SVP, Chief Technology Officer   •       •      –    2021-07-05 4 D $474.85 $135,332 D/D (285) 5,218     -
   Tousi Susan H SVP, Chief Commercial Officer   •       •      –    2021-06-28 4 AS $478.95 $143,685 D/D (300) 43,043 -13%     
   Hoyt Aimee L SVP, Chief People Officer   •       •      –    2021-06-24 4 AS $475.00 $237,500 D/D (500) 4,111 -11%     
   Dadswell Charles SVP & General Counsel   •       •      –    2021-06-22 4 AS $461.01 $144,757 I/I (314) 5,890 -11%     
   Febbo Phillip G. SVP Chief Medical Officer   •       •      –    2021-06-11 4 AS $446.17 $447,589 D/D (1,000) 4,461 -9%     
   Hoyt Aimee L SVP, Chief People Officer   •       •      –    2021-06-10 4 AS $450.00 $225,000 D/D (500) 4,611 -9%     
   Dorsa Caroline Director   •       •      –    2021-06-10 4 AS $450.00 $450,000 D/D (1,000) 8,501 -9%     
   Arnold Frances Director   •       •      –    2021-05-26 4 A $0.00 $0 D/D 881 11,808     -
   Epstein Robert S Director   •       •      –    2021-05-26 4 A $0.00 $0 D/D 881 6,424     -
   Siegel Susan E Director   •       •      –    2021-05-26 4 A $0.00 $0 D/D 881 5,596     -
   Thompson John Wendell Director   •       •      –    2021-05-26 4 A $0.00 $0 D/D 881 8,930     -
   Schiller Philip W Director   •       •      –    2021-05-26 4 A $0.00 $0 D/D 881 10,929     -

  3453 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 139
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed